Omada Health (OMDA) Research & Development (2024 - 2026)

Omada Health has disclosed Research & Development across 3 years of filings, most recently posting $29.9 million for Q2 2026.

• In Q2 2026, Research & Development rose 33.92% year-over-year to $29.9 million; the TTM figure through Jun 2026 stood at $104.2 million (up 33.37% YoY), while the FY2025 annual figure was $90.0 million, up 32.31% from the prior year.
• Research & Development came in at $29.9 million for Q2 2026 at Omada Health, up from $26.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $29.9 million in Q2 2026 to a low of $15.2 million in Q2 2024.
• Average Research & Development over 3 years is $22.0 million, with a median of $22.3 million recorded in 2025.
• The largest YoY upside for Research & Development was 46.92% in 2025 against a maximum downside of 30.53% in 2025.
• Over 3 years, Research & Development stood at $18.1 million in 2024, then jumped by 36.07% to $24.6 million in 2025, then rose by 21.43% to $29.9 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $29.9 million in Q2 2026, $26.8 million in Q1 2026, and $24.6 million in Q4 2025.